Apoptosis
Environmental UV-A and UV-B threshold doses for treating fibroblasts estimated
Published in Cancer Weekly, August 9th, 2005
"Apoptosis involves a highly organized and programmed series of events aimed at maintaining genomic stability by eliminating defective host cells. The purpose of this study was to determine the threshold doses and environmental UV-A and UV-B exposure times necessary to produce apoptosis and necrosis in the normal cells of a human fibroblast cell line," researchers in the United States reported.
"Environmental UV-A and UV-B doses were measured over a 6 year period with a four-channel UV radiometer. The fibroblasts were irradiated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-08-09)
More Articles from Cancer Weekly
- Cancer Registries
Cases reported to cancer registries hampered by time delays - Colon Cancer
Early life events related to later risk of colorectal cancer - Cyclophosphamide
Dermal exposure to cyclophosphamide in hospitals discussed - Osteoporosis
Attention focused on emerging oral complication from supportive cancer therapy - Adverse Drug Reactions
Etanercept therapy for rheumatoid arthritis evaluated over 4 years - Alternative Medicine
Alternative approach to neurolysis is successful in blocking pelvic pain - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
